Condition
Locally Advanced or Metastatic NSCLC clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Locally Advanced or Metastatic NSCLC clinical trials that are recruiting, in China. By phase: Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
ASKC202 with Limertinib combo vs platinum chemo after EGFR-TKI in MET-aligned NSCLC
This trial tests whether ASKC202 plus Limertinib works better than standard platinum-based chemotherapy for adults with locally advanced or metastatic NSCLC that has MET amplification/overexpression after failing EGFR-TKI therapy.
-
HS-10504 for advanced or metastatic non-small-cell lung cancer
This Phase 1 trial tests HS-10504, a fourth-generation EGFR inhibitor, in adults with advanced or metastatic EGFR-positive NSCLC who have progressed after prior EGFR-TKI therapy.
Quick answers
How many Locally Advanced or Metastatic NSCLC clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.